Reference health

Identification of a Novel Family of BRAF<sup>V600E</sup> Inhibitors

https://doi.org/10.1021/jm3004416
CiteStamped reference-health badge
26/26 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 26 checked references that resolve
resolves10.1038/nrm1498
The RAF proteins take centre stage
resolves10.1016/S0925-4773(99)00276-2
Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis
resolves10.1038/nature00766
Mutations of the BRAF gene in human cancer
resolves10.1038/nature05610
Patterns of somatic mutation in human cancer genomes
resolves10.2174/187152011795347469
BRAF as a Target for Cancer Therapy
resolves10.1186/1741-7015-10-23
Therapy for metastatic melanoma: the past, present, and future
resolves10.1016/j.bmcl.2011.11.060
Small molecule inhibitors of BRAF in clinical trials
resolves10.1016/S0092-8674(04)00215-6
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
resolves10.1056/NEJMoa1103782
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
resolves10.1038/nature10662
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
resolves10.1158/0008-5472.CAN-11-1243
Resistance to BRAF Inhibitors: Unraveling Mechanisms and Future Treatment Options
resolves10.1021/jm050983g
Novel Inhibitors of B-RAF Based on a Disubstituted Pyrazine Scaffold. Generation of a Nanomolar Lead
resolves10.1021/jm800539g
Identification of BRAF Inhibitors through In Silico Screening
resolves10.1016/S0169-409X(00)00129-0
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
resolves10.1073/pnas.0711741105
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
resolves10.1021/bi802067u
The Crystal Structure of BRAF in Complex with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of an Active Form of BRAF Kinase
resolves10.1016/j.cell.2009.12.040
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
resolves10.1038/nature08902
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
resolves10.1107/S0907444994003112
The CCP4 suite: programs for protein crystallography
resolves10.1107/S0021889897006766
<i>MOLREP</i>: an Automated Program for Molecular Replacement
resolves10.1107/S0907444998003254
Crystallography &amp; NMR System: A New Software Suite for Macromolecular Structure Determination
resolves10.1055/s-2007-983848
Enantioselective Synthesis of an Analogue of Nanaomycin A
resolves10.1021/cb800039y
Structure-Based Design of an Organoruthenium Phosphatidyl-inositol-3-kinase Inhibitor Reveals a Switch Governing Lipid Kinase Potency and Selectivity
resolves10.1158/0008-5472.CAN-05-1343
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
resolves10.1016/S0002-9440(10)65730-6
Adenoviral Gene Transfer of β3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma
resolves10.1158/1535-7163.MCT-08-0126
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
The 7 references without a DOI — listed, not checked
no DOI — not checkedref3/cit3
no DOI — not checkedref6/cit6
no DOI — not checkedref7/cit7
no DOI — not checkedref24/cit24
no DOI — not checkedLawrence, H.; Ge, Y.; Sebti, S. M.; Guida, W.Proteasome Inhibitors for Selectively Inducing Apoptosis in Cancer Cells. US Patent 20110201609, 2010.
no DOI — not checkedref27/cit27
no DOI — not checkedref33/cit33
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1021/jm3004416"><img src="https://citestamp.com/citestamped/10.1021/jm3004416/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1021/jm3004416/badge.svg)](https://citestamp.com/citestamped/10.1021/jm3004416)